Press "Enter" to skip to content

New patent for Takeda Pharms drug ALUNBRIG

0
Copyright © DrugPatentWatch. Originally published at New patent for Takeda Pharms drug ALUNBRIG

Annual Drug Patent Expirations for ALUNBRIG
Annual Drug Patent Expirations for ALUNBRIG

Alunbrig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has seventy-four patent family members in thirty-seven countries.

The generic ingredient in ALUNBRIG is brigatinib. One supplier is listed for this compound. Additional details are available on the brigatinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Takeda Pharms drug ALUNBRIG
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions